Physician profile
Thomas G Dipasquale
NPI 1770588477
$20,180.17
in general payments reported to CMS, 2019-2025
25 companies · $5,652 in 2025
The $5,652 reported for 2025 was more than what a typical Orthopaedic Trauma provider received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,084 · 2020: $853 · 2021: $1,325 · 2022: $1,368 · 2023: $959 · 2024: $940 · 2025: $5,652.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,173 · Travel and Lodging: $3,377.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,173.44 |
| Travel and Lodging | $3,377.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $7,062.03 | 2019 | |
| Stryker Corporation | $3,685.55 | 2019-2025 | Pro, Gamma, Augment Injectable |
| Zimmer Biomet Holdings, INC. | $1,903.02 | 2019-2025 | Dvr Anatomic Kickstand, Arcos, Avenir |
| Acumed LLC | $1,864.17 | 2025 | Acumed |
| Smith+Nephew, INC. | $1,577.87 | 2019-2025 | Renasys Touch, Pico 7, Pico |
| Sanara Medtech INC. | $739.64 | 2021-2024 | Celleraterx |
| Polynovo North America LLC | $492.26 | 2023-2025 | Novosorb Btm |
| Si-Bone, INC. | $486.24 | 2021-2023 | |
| Depuy Synthes Sales INC. | $482.65 | 2019-2023 | Attune |
| Kuros Biosciences USA, INC | $310.32 | 2024-2025 | Magnetos |
| Aroa Biosurgery Incorporated | $280.80 | 2025 | |
| Davol INC. | $277.18 | 2021-2022 | |
| Integra Lifesciences Corporation | $165.76 | 2022 | |
| My01 INC. | $124.62 | 2023 | My01 Continuous Compartmental Pressure Monitor |
| Skeletal Dynamics INC | $114.74 | 2025 | Implate, Align, Ijs |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $114.29 | 2024 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Ha+ Nerve Protector |
| Restor3d, INC. | $112.11 | 2022-2023 | |
| Arthrex, INC. | $102.69 | 2025 | |
| Avita Medical Americas, LLC | $66.12 | 2025 | Permeaderm, Cohealyx, Recell |
| Heraeus Medical, LLC. | $57.85 | 2020 | |
| Novus Surgical Consultants | $55.03 | 2025 | |
| Medical Device Business Services, INC. | $45.00 | 2019 | |
| Cerapedics INC. | $38.22 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Kerecis Limited | $17.62 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Biocomposites INC | $4.39 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Dipasquale listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.